Cargando…

Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?

BACKGROUND: Insulin resistance (IR) is the major driving force behind development and progression of atherosclerosis in patients with nonalcoholic fatty liver disease (NAFLD). Therefore, correction of IR is a relevant therapeutic target. We performed the current trial to evaluate whether 12- month m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shargorodsky, Marina, Omelchenko, Elena, Matas, Zipora, Boaz, Mona, Gavish, Dov
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471007/ https://www.ncbi.nlm.nih.gov/pubmed/22676459 http://dx.doi.org/10.1186/1475-2840-11-61

Ejemplares similares

Relation of Adiponectin to Glucose Tolerance Status, Adiposity, and Cardiovascular Risk Factor Load
por: Wolfson, N., et al.
Publicado: (2012)

Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery
por: Parker, Brian M., et al.
Publicado: (2017)

Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health
por: Lukich, Alla, et al.
Publicado: (2014)

Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors
por: Shargorodsky, Marina, et al.
Publicado: (2010)

Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in south-Asians
por: Wasim, Hanif, et al.
Publicado: (2006)

Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS)
por: Leibovitz, Eyal, et al.
Publicado: (2013)

The prognostic role of RBP-4 and adiponectin in patients with peripheral arterial disease undergoing lower limb endovascular revascularization
por: Kadoglou, Nikolaos P. E., et al.
Publicado: (2021)

Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment
por: Node, Koichi, et al.
Publicado: (2009)

Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2019)

Combined Adiponectin Deficiency and Resistance in Obese Patients: Can It Solve Part of the Puzzle in Nonalcoholic Steatohepatitis
por: Salman, Ahmed, et al.
Publicado: (2015)

Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease
por: Kollias, Anastasios, et al.
Publicado: (2011)

Differential transendothelial transport of adiponectin complexes
por: Rutkowski, Joseph M, et al.
Publicado: (2014)

Sildenafil augments fetal weight and placental adiponectin in gestational testosterone-induced glucose intolerant rats
por: Areola, Emmanuel Damilare, et al.
Publicado: (2021)

Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
por: Horakova, Olga, et al.
Publicado: (2019)

Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls
por: Bavoso, Nádia Couto, et al.
Publicado: (2019)

Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome
por: Broedl, Uli C, et al.
Publicado: (2006)

The Effects of Combined Adiponectin-Metformin on Glucose and Lipids Levels in Mice and Acute Toxicity and Anti-Ulcerogenic Activity of Adiponectin Against Ethanol-Induced Gastric Mucosal Injuries in Rat
por: Fard, Atieh A., et al.
Publicado: (2011)

Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis
por: Clarke, John D., et al.
Publicado: (2015)

Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation
por: Moonira, Tabassum, et al.
Publicado: (2020)

Westernization of lifestyle affects quantitative and qualitative changes in adiponectin
por: Kubota, Mitsunobu, et al.
Publicado: (2017)

Recombinant Adiponectin Does Not Lower Plasma Glucose in Animal Models of Type 2 Diabetes
por: Tullin, Søren, et al.
Publicado: (2012)

Metformin Affects Heme Function as a Possible Mechanism of Action
por: Li, Xiyan, et al.
Publicado: (2018)

Adiponectin, diabetes and ischemic heart failure: a challenging relationship
por: Baldasseroni, Samuele, et al.
Publicado: (2012)

Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats
por: Schmid, Peter M, et al.
Publicado: (2013)

Metformin Cessation and Dementia Incidence
por: Zimmerman, Scott C., et al.
Publicado: (2023)

Metformin in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial
por: Kazemi, Rozana, et al.
Publicado: (2012)

Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults
por: Wurm, Sylvia, et al.
Publicado: (2007)

PPARγ Agonist Beyond Glucose Lowering Effect
por: Sugawara, Akira, et al.
Publicado: (2011)

SGLT2i: beyond the glucose-lowering effect
por: Ni, Lihua, et al.
Publicado: (2020)

Urinary adiponectin concentration is positively associated with micro- and macro-vascular complications
por: Jeon, Won Seon, et al.
Publicado: (2013)

Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus
por: Lekva, Tove, et al.
Publicado: (2017)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies
por: Chang, Shang-Hung, et al.
Publicado: (2014)

Editorial: Metformin: Beyond Diabetes
por: Bost, Frédéric, et al.
Publicado: (2019)

Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B(2) level in aspirin-treated patients with type 2 diabetes: an observational study
por: Kaplon-Cieslicka, Agnieszka, et al.
Publicado: (2014)

Waist circumference does not predict circulating adiponectin levels in sub-Saharan women
por: Sobngwi, Eugène, et al.
Publicado: (2007)

Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study
por: Hansen, Christian Stevns, et al.
Publicado: (2017)

The association between serum adiponectin and 3-month outcome after ischemic stroke
por: Wang, Zengliang, et al.
Publicado: (2019)

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2017)

Plasma Adiponectin and Its Correlation with Carotid Intima-Media Thickness in Obesity and in Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
por: Hussein, Maha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e4iqupkcffl6m8jmumere2fn1l